ATE494308T1 - Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon - Google Patents

Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon

Info

Publication number
ATE494308T1
ATE494308T1 AT06818579T AT06818579T ATE494308T1 AT E494308 T1 ATE494308 T1 AT E494308T1 AT 06818579 T AT06818579 T AT 06818579T AT 06818579 T AT06818579 T AT 06818579T AT E494308 T1 ATE494308 T1 AT E494308T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
production processes
new derivatives
formula
group
Prior art date
Application number
AT06818579T
Other languages
English (en)
Inventor
Marguerite Rinaudo
Rachel Auzely
Shirin Kadi
Anthony Bresin
Erell Kubik
Original Assignee
Centre Nat Rech Scient
Ard Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Ard Sa filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE494308T1 publication Critical patent/ATE494308T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
AT06818579T 2005-11-22 2006-11-16 Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon ATE494308T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05292474 2005-11-22
PCT/EP2006/010991 WO2007059890A1 (en) 2005-11-22 2006-11-16 New derivatives of hyaluronic acid, their preparation process and their uses

Publications (1)

Publication Number Publication Date
ATE494308T1 true ATE494308T1 (de) 2011-01-15

Family

ID=35686594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06818579T ATE494308T1 (de) 2005-11-22 2006-11-16 Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon

Country Status (6)

Country Link
US (1) US8039447B2 (de)
EP (1) EP1951761B1 (de)
JP (1) JP2009516765A (de)
AT (1) ATE494308T1 (de)
DE (1) DE602006019474D1 (de)
WO (1) WO2007059890A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
KR101594552B1 (ko) 2008-04-04 2016-02-17 유니버시티 오브 유타 리서치 파운데이션 알킬화된 반합성 글리코사미노글리코산 에테르 및 이의 제조 및 사용 방법
WO2009134344A1 (en) * 2008-04-28 2009-11-05 Surmodics, Inc. POLY-α(1→4)GLUCOPYRANOSE-BASED MATRICES WITH HYDRAZIDE CROSSLINKING
EP2688402B1 (de) 2011-03-23 2018-10-24 University of Utah Research Foundation Mittel zur behandlung bzw. prävention von harnwegsentzündungen
WO2013109959A1 (en) * 2012-01-18 2013-07-25 University Of Kansas Hyaluronic acid particles and their use in biomedical applications
PL3019177T3 (pl) * 2013-07-10 2021-04-19 Matrix Biology Institute Kompozycje hialuronianu o dużej sprężystości i ich zastosowania
HUE054874T2 (hu) 2015-09-24 2021-10-28 Matrix Biology Inst Magas elaszticitású hialuronán készítmények és alkalmazási eljárások
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN106832056B (zh) * 2017-02-24 2019-08-06 中国药科大学 硫酸化透明质酸2-辛基十二醇酯
CN107162144B (zh) * 2017-07-09 2020-03-10 湖南金裕环保科技有限公司 功能性漆雾凝聚剂、制备方法及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
WO2002006373A1 (en) 2000-07-17 2002-01-24 University Of Utah Research Foundation Hydrogel films and methods of making and using therefor
US20040234497A1 (en) * 2001-05-04 2004-11-25 Yi Luo Hyaluronic acid containing bioconjugates:targeted delivery of anti-cancer drugs to cancer cells
US7767806B2 (en) * 2003-09-08 2010-08-03 Chugai Seiyaku Kabushiki Kaisha Hyaluronic acid modification products and drug carriers using them
JP4993465B2 (ja) * 2003-12-04 2012-08-08 ユニバーシティ オブ ユタ リサーチ ファウンデーション 変性された高分子ならびにその製造方法および使用方法

Also Published As

Publication number Publication date
EP1951761B1 (de) 2011-01-05
JP2009516765A (ja) 2009-04-23
US8039447B2 (en) 2011-10-18
US20080306023A1 (en) 2008-12-11
EP1951761A1 (de) 2008-08-06
WO2007059890A1 (en) 2007-05-31
DE602006019474D1 (de) 2011-02-17

Similar Documents

Publication Publication Date Title
ATE494308T1 (de) Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon
SG195214A1 (en) Long chain glycolipids useful to avoid perishing or microbial contaminationof materials
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
TW200607494A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
MX2009005731A (es) Composicion antimicrobiana para acabado de textiles.
BRPI0514137A (pt) uso de pelo menos um composto heterocìclico, composição de combustìvel, concentrado de aditivos, e, processo para preparar uma composição de combustìvel
MX2011012366A (es) Mezclas fungicidas sinergeticas.
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
ATE332887T1 (de) Naturstoffe und deren derivate zur prävention und behandlung von herzkreislauf-, leber- und nierenerkrankungen und für kosmetische anwendungen
TN2011000053A1 (en) Organic compounds
CO6351737A2 (es) Amidofenoxiindazoles utiles como inhibidores de c-met
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
TW200716519A (en) Benzoyl-substituted serineamides
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
EA200870282A1 (ru) Производные амина
MX2013004242A (es) Sulfonamidas nematocidas.
NO20083590L (no) Biocidblandinger inneholdende pyrition- og pyrrolderivativer
IL209650A0 (en) Novel compound having affinity for amyloid
IN2012DN00758A (de)
EA200870174A1 (ru) Отверждающие агенты для эпокси-функциональных соединений
BRPI1016069A8 (pt) Misturas de ésteres e composições compreendendo tais misturas de ésteres
EA201070250A1 (ru) Противомикробный парентеральный состав

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties